NBC News chief foreign correspondent Richard Engel announced Thursday that his 6-year-old son, Henry, had died after being diagnosed as an infant with a rare genetic neurological disorder called Rett ...
Gene therapy may offer hope for people with a rare childhood disease called Rett syndrome. Around one in 10,000 girls are born each year with Rett syndrome, a rare genetic condition that impacts brain ...
Rett syndrome is a rare neurodevelopment disorder that leads to developmental regression, usually after a period of normal growth, and causes impairments in communication, motor skills, and speech. It ...
To better understand what drives the emergence of symptoms in Rett syndrome, researchers at Baylor College of Medicine and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children's ...
Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...
InvestorsHub on MSN
Taysha Advances Rett Syndrome Programme as Pivotal Trial Enrollment Completes (TSHA)
Taysha Gene Therapies Inc (NASDAQ:TSHA) shares rose 3.6% in premarket trading on Monday after the company announced the ...
Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced updated, ...
Acadia Pharmaceuticals Inc. ACAD shares are trading higher on Friday as the company is celebrating a positive recommendation ...
When evaluating the significance of some intervention, randomized-control trials are our gold standard. However, randomized-control trials are usually constrained by time and hindered by some bias. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results